Cite
MLA Citation
Peter Martin et al.. “To the Editor, A multicenter, open-label, early access treatment protocol for ibrutinib in patients with relapsed or refractory mantle cell lymphoma.” Journal of oncology pharmacy practice, vol. 25, 2019, pp. 1027–1030. http://access.bl.uk/ark:/81055/vdc_100081284819.0x000075